nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2A6—Progesterone—uterine cancer	0.195	0.228	CbGbCtD
Methimazole—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.101	0.118	CbGbCtD
Methimazole—CYP2C19—Progesterone—uterine cancer	0.0807	0.0943	CbGbCtD
Methimazole—CYP1A2—Progesterone—uterine cancer	0.0745	0.087	CbGbCtD
Methimazole—CYP2C9—Progesterone—uterine cancer	0.0671	0.0784	CbGbCtD
Methimazole—CYP2D6—Progesterone—uterine cancer	0.0614	0.0717	CbGbCtD
Methimazole—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0589	0.0688	CbGbCtD
Methimazole—CYP2E1—Etoposide—uterine cancer	0.0576	0.0673	CbGbCtD
Methimazole—CYP3A4—Progesterone—uterine cancer	0.039	0.0456	CbGbCtD
Methimazole—CYP2B6—Doxorubicin—uterine cancer	0.0388	0.0453	CbGbCtD
Methimazole—CYP1A2—Etoposide—uterine cancer	0.0333	0.0389	CbGbCtD
Methimazole—CYP2D6—Doxorubicin—uterine cancer	0.0187	0.0219	CbGbCtD
Methimazole—CYP3A4—Etoposide—uterine cancer	0.0175	0.0204	CbGbCtD
Methimazole—CYP3A4—Doxorubicin—uterine cancer	0.0119	0.0139	CbGbCtD
Methimazole—Pigmentation disorder—Etoposide—uterine cancer	0.00504	0.0437	CcSEcCtD
Methimazole—Neuritis—Progesterone—uterine cancer	0.0044	0.0382	CcSEcCtD
Methimazole—Neuritis—Medroxyprogesterone Acetate—uterine cancer	0.00399	0.0346	CcSEcCtD
Methimazole—Pigmentation disorder—Epirubicin—uterine cancer	0.00282	0.0245	CcSEcCtD
Methimazole—Lymphadenopathy—Progesterone—uterine cancer	0.0028	0.0243	CcSEcCtD
Methimazole—Pigmentation disorder—Doxorubicin—uterine cancer	0.00261	0.0227	CcSEcCtD
Methimazole—Aplastic anaemia—Dactinomycin—uterine cancer	0.00218	0.0189	CcSEcCtD
Methimazole—Drowsiness—Progesterone—uterine cancer	0.00184	0.0159	CcSEcCtD
Methimazole—Neuropathy peripheral—Progesterone—uterine cancer	0.0018	0.0156	CcSEcCtD
Methimazole—Jaundice—Progesterone—uterine cancer	0.00179	0.0155	CcSEcCtD
Methimazole—Body temperature increased—Carboplatin—uterine cancer	0.00176	0.0153	CcSEcCtD
Methimazole—Drowsiness—Medroxyprogesterone Acetate—uterine cancer	0.00167	0.0145	CcSEcCtD
Methimazole—Hepatitis—Progesterone—uterine cancer	0.00165	0.0143	CcSEcCtD
Methimazole—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.0142	CcSEcCtD
Methimazole—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00162	0.0141	CcSEcCtD
Methimazole—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.013	CcSEcCtD
Methimazole—Alopecia—Progesterone—uterine cancer	0.00146	0.0127	CcSEcCtD
Methimazole—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00132	0.0115	CcSEcCtD
Methimazole—Vertigo—Progesterone—uterine cancer	0.00129	0.0112	CcSEcCtD
Methimazole—Neuritis—Epirubicin—uterine cancer	0.00126	0.0109	CcSEcCtD
Methimazole—Arthralgia—Progesterone—uterine cancer	0.00122	0.0106	CcSEcCtD
Methimazole—Myalgia—Progesterone—uterine cancer	0.00122	0.0106	CcSEcCtD
Methimazole—Agranulocytosis—Dactinomycin—uterine cancer	0.00121	0.0105	CcSEcCtD
Methimazole—Oedema—Progesterone—uterine cancer	0.00117	0.0102	CcSEcCtD
Methimazole—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00117	0.0101	CcSEcCtD
Methimazole—Neuritis—Doxorubicin—uterine cancer	0.00117	0.0101	CcSEcCtD
Methimazole—Hepatitis—Dactinomycin—uterine cancer	0.00117	0.0101	CcSEcCtD
Methimazole—Ageusia—Epirubicin—uterine cancer	0.00116	0.0101	CcSEcCtD
Methimazole—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00961	CcSEcCtD
Methimazole—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00111	0.00961	CcSEcCtD
Methimazole—Ageusia—Doxorubicin—uterine cancer	0.00108	0.00934	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00107	0.00927	CcSEcCtD
Methimazole—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.00922	CcSEcCtD
Methimazole—Paraesthesia—Progesterone—uterine cancer	0.00105	0.00913	CcSEcCtD
Methimazole—Somnolence—Progesterone—uterine cancer	0.00104	0.00904	CcSEcCtD
Methimazole—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00104	0.00902	CcSEcCtD
Methimazole—Dyspepsia—Progesterone—uterine cancer	0.00103	0.00895	CcSEcCtD
Methimazole—Alopecia—Dactinomycin—uterine cancer	0.00103	0.00894	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000968	0.0084	CcSEcCtD
Methimazole—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000954	0.00828	CcSEcCtD
Methimazole—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000945	0.00819	CcSEcCtD
Methimazole—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00811	CcSEcCtD
Methimazole—Urticaria—Progesterone—uterine cancer	0.000932	0.00808	CcSEcCtD
Methimazole—Body temperature increased—Progesterone—uterine cancer	0.000927	0.00804	CcSEcCtD
Methimazole—Neuropathy peripheral—Etoposide—uterine cancer	0.000922	0.008	CcSEcCtD
Methimazole—Jaundice—Etoposide—uterine cancer	0.000917	0.00795	CcSEcCtD
Methimazole—Leukopenia—Dactinomycin—uterine cancer	0.000909	0.00788	CcSEcCtD
Methimazole—Aplastic anaemia—Epirubicin—uterine cancer	0.000885	0.00768	CcSEcCtD
Methimazole—Agranulocytosis—Etoposide—uterine cancer	0.000878	0.00761	CcSEcCtD
Methimazole—Myalgia—Dactinomycin—uterine cancer	0.000865	0.0075	CcSEcCtD
Methimazole—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000844	0.00732	CcSEcCtD
Methimazole—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00084	0.00729	CcSEcCtD
Methimazole—Pruritus—Progesterone—uterine cancer	0.00083	0.0072	CcSEcCtD
Methimazole—Oedema—Dactinomycin—uterine cancer	0.000829	0.00719	CcSEcCtD
Methimazole—Aplastic anaemia—Doxorubicin—uterine cancer	0.000819	0.0071	CcSEcCtD
Methimazole—Thrombocytopenia—Dactinomycin—uterine cancer	0.000812	0.00704	CcSEcCtD
Methimazole—Lymphadenopathy—Epirubicin—uterine cancer	0.000802	0.00696	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000755	0.00655	CcSEcCtD
Methimazole—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000752	0.00652	CcSEcCtD
Methimazole—Alopecia—Etoposide—uterine cancer	0.000746	0.00647	CcSEcCtD
Methimazole—Vomiting—Progesterone—uterine cancer	0.000746	0.00647	CcSEcCtD
Methimazole—Lymphadenopathy—Doxorubicin—uterine cancer	0.000742	0.00644	CcSEcCtD
Methimazole—Rash—Progesterone—uterine cancer	0.000739	0.00641	CcSEcCtD
Methimazole—Dermatitis—Progesterone—uterine cancer	0.000739	0.00641	CcSEcCtD
Methimazole—Headache—Progesterone—uterine cancer	0.000735	0.00637	CcSEcCtD
Methimazole—Nausea—Progesterone—uterine cancer	0.000697	0.00604	CcSEcCtD
Methimazole—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000676	0.00586	CcSEcCtD
Methimazole—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00067	0.00581	CcSEcCtD
Methimazole—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000669	0.00581	CcSEcCtD
Methimazole—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000666	0.00577	CcSEcCtD
Methimazole—Vertigo—Etoposide—uterine cancer	0.00066	0.00573	CcSEcCtD
Methimazole—Leukopenia—Etoposide—uterine cancer	0.000658	0.00571	CcSEcCtD
Methimazole—Body temperature increased—Dactinomycin—uterine cancer	0.000655	0.00568	CcSEcCtD
Methimazole—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000631	0.00547	CcSEcCtD
Methimazole—Thrombocytopenia—Etoposide—uterine cancer	0.000587	0.00509	CcSEcCtD
Methimazole—Paraesthesia—Etoposide—uterine cancer	0.000539	0.00467	CcSEcCtD
Methimazole—Somnolence—Etoposide—uterine cancer	0.000533	0.00463	CcSEcCtD
Methimazole—Drowsiness—Epirubicin—uterine cancer	0.000527	0.00457	CcSEcCtD
Methimazole—Vomiting—Dactinomycin—uterine cancer	0.000527	0.00457	CcSEcCtD
Methimazole—Rash—Dactinomycin—uterine cancer	0.000523	0.00453	CcSEcCtD
Methimazole—Neuropathy peripheral—Epirubicin—uterine cancer	0.000517	0.00448	CcSEcCtD
Methimazole—Jaundice—Epirubicin—uterine cancer	0.000514	0.00446	CcSEcCtD
Methimazole—Nausea—Dactinomycin—uterine cancer	0.000492	0.00427	CcSEcCtD
Methimazole—Agranulocytosis—Epirubicin—uterine cancer	0.000492	0.00427	CcSEcCtD
Methimazole—Drowsiness—Doxorubicin—uterine cancer	0.000488	0.00423	CcSEcCtD
Methimazole—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000478	0.00415	CcSEcCtD
Methimazole—Urticaria—Etoposide—uterine cancer	0.000477	0.00413	CcSEcCtD
Methimazole—Jaundice—Doxorubicin—uterine cancer	0.000476	0.00412	CcSEcCtD
Methimazole—Body temperature increased—Etoposide—uterine cancer	0.000474	0.00411	CcSEcCtD
Methimazole—Hepatitis—Epirubicin—uterine cancer	0.000473	0.00411	CcSEcCtD
Methimazole—Agranulocytosis—Doxorubicin—uterine cancer	0.000455	0.00395	CcSEcCtD
Methimazole—Hepatitis—Doxorubicin—uterine cancer	0.000438	0.0038	CcSEcCtD
Methimazole—Pruritus—Etoposide—uterine cancer	0.000424	0.00368	CcSEcCtD
Methimazole—Alopecia—Epirubicin—uterine cancer	0.000418	0.00363	CcSEcCtD
Methimazole—Alopecia—Doxorubicin—uterine cancer	0.000387	0.00336	CcSEcCtD
Methimazole—Vomiting—Etoposide—uterine cancer	0.000381	0.00331	CcSEcCtD
Methimazole—Rash—Etoposide—uterine cancer	0.000378	0.00328	CcSEcCtD
Methimazole—Dermatitis—Etoposide—uterine cancer	0.000378	0.00328	CcSEcCtD
Methimazole—Headache—Etoposide—uterine cancer	0.000376	0.00326	CcSEcCtD
Methimazole—Vertigo—Epirubicin—uterine cancer	0.00037	0.00321	CcSEcCtD
Methimazole—Leukopenia—Epirubicin—uterine cancer	0.000369	0.0032	CcSEcCtD
Methimazole—Nausea—Etoposide—uterine cancer	0.000356	0.00309	CcSEcCtD
Methimazole—Arthralgia—Epirubicin—uterine cancer	0.000351	0.00304	CcSEcCtD
Methimazole—Myalgia—Epirubicin—uterine cancer	0.000351	0.00304	CcSEcCtD
Methimazole—Vertigo—Doxorubicin—uterine cancer	0.000343	0.00297	CcSEcCtD
Methimazole—Leukopenia—Doxorubicin—uterine cancer	0.000341	0.00296	CcSEcCtD
Methimazole—Oedema—Epirubicin—uterine cancer	0.000336	0.00292	CcSEcCtD
Methimazole—Thrombocytopenia—Epirubicin—uterine cancer	0.000329	0.00286	CcSEcCtD
Methimazole—Myalgia—Doxorubicin—uterine cancer	0.000325	0.00282	CcSEcCtD
Methimazole—Arthralgia—Doxorubicin—uterine cancer	0.000325	0.00282	CcSEcCtD
Methimazole—Oedema—Doxorubicin—uterine cancer	0.000311	0.0027	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000306	0.00266	CcSEcCtD
Methimazole—Thrombocytopenia—Doxorubicin—uterine cancer	0.000305	0.00264	CcSEcCtD
Methimazole—Paraesthesia—Epirubicin—uterine cancer	0.000302	0.00262	CcSEcCtD
Methimazole—Somnolence—Epirubicin—uterine cancer	0.000299	0.00259	CcSEcCtD
Methimazole—Dyspepsia—Epirubicin—uterine cancer	0.000296	0.00257	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000283	0.00246	CcSEcCtD
Methimazole—Paraesthesia—Doxorubicin—uterine cancer	0.000279	0.00242	CcSEcCtD
Methimazole—Somnolence—Doxorubicin—uterine cancer	0.000277	0.0024	CcSEcCtD
Methimazole—Dyspepsia—Doxorubicin—uterine cancer	0.000274	0.00238	CcSEcCtD
Methimazole—Urticaria—Epirubicin—uterine cancer	0.000267	0.00232	CcSEcCtD
Methimazole—Body temperature increased—Epirubicin—uterine cancer	0.000266	0.00231	CcSEcCtD
Methimazole—Urticaria—Doxorubicin—uterine cancer	0.000247	0.00214	CcSEcCtD
Methimazole—Body temperature increased—Doxorubicin—uterine cancer	0.000246	0.00213	CcSEcCtD
Methimazole—Pruritus—Epirubicin—uterine cancer	0.000238	0.00206	CcSEcCtD
Methimazole—Pruritus—Doxorubicin—uterine cancer	0.00022	0.00191	CcSEcCtD
Methimazole—Vomiting—Epirubicin—uterine cancer	0.000214	0.00185	CcSEcCtD
Methimazole—Rash—Epirubicin—uterine cancer	0.000212	0.00184	CcSEcCtD
Methimazole—Dermatitis—Epirubicin—uterine cancer	0.000212	0.00184	CcSEcCtD
Methimazole—Headache—Epirubicin—uterine cancer	0.000211	0.00183	CcSEcCtD
Methimazole—Nausea—Epirubicin—uterine cancer	0.0002	0.00173	CcSEcCtD
Methimazole—Vomiting—Doxorubicin—uterine cancer	0.000198	0.00172	CcSEcCtD
Methimazole—Rash—Doxorubicin—uterine cancer	0.000196	0.0017	CcSEcCtD
Methimazole—Dermatitis—Doxorubicin—uterine cancer	0.000196	0.0017	CcSEcCtD
Methimazole—Headache—Doxorubicin—uterine cancer	0.000195	0.00169	CcSEcCtD
Methimazole—Nausea—Doxorubicin—uterine cancer	0.000185	0.0016	CcSEcCtD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.00011	0.00379	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—AKR1B10—uterine cancer	0.00011	0.00378	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	0.00011	0.00378	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—GPX3—uterine cancer	0.000109	0.00377	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	0.000106	0.00365	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	0.000105	0.00363	CbGpPWpGaD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	0.000104	0.0036	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	0.000104	0.00358	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP11A1—uterine cancer	0.000103	0.00355	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—TP53—uterine cancer	0.000103	0.00353	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—AKR1B1—uterine cancer	0.000102	0.00352	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP11A1—uterine cancer	0.000102	0.0035	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.000101	0.00349	CbGpPWpGaD
Methimazole—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	0.000101	0.00348	CbGpPWpGaD
Methimazole—TPO—Metabolism—RRM2—uterine cancer	0.000101	0.00346	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	0.0001	0.00346	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	9.8e-05	0.00338	CbGpPWpGaD
Methimazole—TPO—Metabolism—DCN—uterine cancer	9.76e-05	0.00336	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	9.62e-05	0.00331	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—AKR1C3—uterine cancer	9.6e-05	0.00331	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP19A1—uterine cancer	9.59e-05	0.00331	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP11A1—uterine cancer	9.19e-05	0.00317	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	9e-05	0.0031	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—AKR1C1—uterine cancer	8.85e-05	0.00305	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	8.77e-05	0.00302	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—uterine cancer	8.74e-05	0.00301	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKR1C3—uterine cancer	8.68e-05	0.00299	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.58e-05	0.00296	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	8.48e-05	0.00292	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	8.45e-05	0.00291	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	8.17e-05	0.00281	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	8.06e-05	0.00278	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	7.95e-05	0.00274	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	7.88e-05	0.00272	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	7.84e-05	0.0027	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—GPX3—uterine cancer	7.77e-05	0.00268	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	7.74e-05	0.00267	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	7.7e-05	0.00265	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	7.64e-05	0.00263	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP19A1—uterine cancer	7.58e-05	0.00261	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—AKR1C1—uterine cancer	7.5e-05	0.00258	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP19A1—uterine cancer	7.48e-05	0.00258	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	7.41e-05	0.00255	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP11A1—uterine cancer	7.31e-05	0.00252	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	7.25e-05	0.0025	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP11A1—uterine cancer	7.21e-05	0.00249	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	7.15e-05	0.00246	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	7.06e-05	0.00243	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—AKR1C3—uterine cancer	6.81e-05	0.00235	CbGpPWpGaD
Methimazole—TPO—Metabolism—STK11—uterine cancer	6.76e-05	0.00233	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP19A1—uterine cancer	6.76e-05	0.00233	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	6.75e-05	0.00233	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.62e-05	0.00228	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—GPX3—uterine cancer	6.58e-05	0.00227	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	6.44e-05	0.00222	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP11A1—uterine cancer	6.2e-05	0.00213	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP11A1—uterine cancer	6.11e-05	0.00211	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	5.94e-05	0.00205	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	5.94e-05	0.00205	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	5.85e-05	0.00202	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	5.78e-05	0.00199	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—AKR1C3—uterine cancer	5.77e-05	0.00199	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	5.77e-05	0.00199	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	5.5e-05	0.00189	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP19A1—uterine cancer	5.38e-05	0.00185	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	5.33e-05	0.00184	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP19A1—uterine cancer	5.31e-05	0.00183	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	5.26e-05	0.00181	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	5.22e-05	0.0018	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—uterine cancer	5.22e-05	0.0018	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—NDUFB11—uterine cancer	5.16e-05	0.00178	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SRD5A2—uterine cancer	5.16e-05	0.00178	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	5.1e-05	0.00176	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	5.1e-05	0.00176	CbGpPWpGaD
Methimazole—TPO—Metabolism—MTHFR—uterine cancer	5.08e-05	0.00175	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	5.08e-05	0.00175	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	4.94e-05	0.0017	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	4.88e-05	0.00168	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	4.78e-05	0.00165	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	4.72e-05	0.00162	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	4.65e-05	0.0016	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	4.65e-05	0.0016	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	4.56e-05	0.00157	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	4.5e-05	0.00155	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	4.45e-05	0.00153	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	4.2e-05	0.00145	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SRD5A2—uterine cancer	4.16e-05	0.00143	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—NDUFB11—uterine cancer	4.16e-05	0.00143	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SRD5A2—uterine cancer	4.07e-05	0.0014	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—NDUFB11—uterine cancer	4.07e-05	0.0014	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.98e-05	0.00137	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.98e-05	0.00137	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.75e-05	0.00129	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKR1B1—uterine cancer	3.73e-05	0.00128	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—STAR—uterine cancer	3.73e-05	0.00128	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	3.57e-05	0.00123	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	3.52e-05	0.00121	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	3.47e-05	0.0012	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	3.42e-05	0.00118	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—NDUFB11—uterine cancer	3.14e-05	0.00108	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SRD5A2—uterine cancer	3.14e-05	0.00108	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	3.05e-05	0.00105	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKR1B1—uterine cancer	3.01e-05	0.00104	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—STAR—uterine cancer	3.01e-05	0.00104	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKR1B1—uterine cancer	2.95e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—STAR—uterine cancer	2.95e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POLD1—uterine cancer	2.92e-05	0.00101	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.92e-05	0.00101	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.89e-05	0.000996	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.89e-05	0.000996	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.88e-05	0.000993	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SRD5A2—uterine cancer	2.87e-05	0.000987	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—NDUFB11—uterine cancer	2.87e-05	0.000987	CbGpPWpGaD
Methimazole—TPO—Metabolism—PTEN—uterine cancer	2.83e-05	0.000974	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.78e-05	0.000959	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKR1C1—uterine cancer	2.74e-05	0.000943	CbGpPWpGaD
Methimazole—TPO—Metabolism—EP300—uterine cancer	2.7e-05	0.000929	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.63e-05	0.000906	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SRD5A2—uterine cancer	2.45e-05	0.000844	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—NDUFB11—uterine cancer	2.45e-05	0.000844	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—RRM2—uterine cancer	2.44e-05	0.00084	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.38e-05	0.00082	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—DCN—uterine cancer	2.37e-05	0.000816	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POLD1—uterine cancer	2.36e-05	0.000813	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POLD1—uterine cancer	2.31e-05	0.000796	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—STAR—uterine cancer	2.27e-05	0.000783	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKR1B1—uterine cancer	2.27e-05	0.000783	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.25e-05	0.000774	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.25e-05	0.000774	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP11A1—uterine cancer	2.23e-05	0.000768	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKR1C1—uterine cancer	2.21e-05	0.000761	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKR1C1—uterine cancer	2.16e-05	0.000745	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKR1C3—uterine cancer	2.11e-05	0.000726	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—STAR—uterine cancer	2.09e-05	0.00072	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.09e-05	0.00072	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKR1B1—uterine cancer	2.07e-05	0.000714	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—STAR—uterine cancer	2.07e-05	0.000714	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.05e-05	0.000706	CbGpPWpGaD
Methimazole—TPO—Metabolism—PIK3CA—uterine cancer	1.99e-05	0.000687	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—RRM2—uterine cancer	1.97e-05	0.000678	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—RRM2—uterine cancer	1.93e-05	0.000664	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—DCN—uterine cancer	1.91e-05	0.000658	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.89e-05	0.000651	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.89e-05	0.000651	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—DCN—uterine cancer	1.87e-05	0.000645	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.8e-05	0.00062	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POLD1—uterine cancer	1.78e-05	0.000614	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.77e-05	0.00061	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—STAR—uterine cancer	1.77e-05	0.00061	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.76e-05	0.000607	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.75e-05	0.000603	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.7e-05	0.000585	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.67e-05	0.000575	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.66e-05	0.000573	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.64e-05	0.000565	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—STK11—uterine cancer	1.64e-05	0.000565	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POLD1—uterine cancer	1.64e-05	0.000565	CbGpPWpGaD
Methimazole—TPO—Metabolism—AKT1—uterine cancer	1.63e-05	0.000561	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POLD1—uterine cancer	1.63e-05	0.00056	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.53e-05	0.000529	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.52e-05	0.000524	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—RRM2—uterine cancer	1.49e-05	0.000512	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—DCN—uterine cancer	1.44e-05	0.000497	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POLD1—uterine cancer	1.39e-05	0.000479	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—RRM2—uterine cancer	1.37e-05	0.000471	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.37e-05	0.000471	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—STAR—uterine cancer	1.37e-05	0.000471	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP11A1—uterine cancer	1.36e-05	0.000468	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—RRM2—uterine cancer	1.36e-05	0.000467	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—DCN—uterine cancer	1.33e-05	0.000457	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—STK11—uterine cancer	1.32e-05	0.000456	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP19A1—uterine cancer	1.32e-05	0.000456	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—DCN—uterine cancer	1.32e-05	0.000453	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKR1C1—uterine cancer	1.3e-05	0.000448	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—STK11—uterine cancer	1.3e-05	0.000447	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP19A1—uterine cancer	1.3e-05	0.000447	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKR1C3—uterine cancer	1.28e-05	0.000442	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.25e-05	0.000431	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.24e-05	0.000427	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—MTHFR—uterine cancer	1.23e-05	0.000425	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.18e-05	0.000407	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.17e-05	0.000403	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RRM2—uterine cancer	1.16e-05	0.000399	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—DCN—uterine cancer	1.12e-05	0.000387	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POLD1—uterine cancer	1.07e-05	0.000369	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP11A1—uterine cancer	1.06e-05	0.000365	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKR1C1—uterine cancer	1e-05	0.000346	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKR1C3—uterine cancer	1e-05	0.000345	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—STK11—uterine cancer	1e-05	0.000345	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP19A1—uterine cancer	1e-05	0.000345	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—MTHFR—uterine cancer	9.95e-06	0.000343	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—MTHFR—uterine cancer	9.74e-06	0.000336	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.39e-06	0.000324	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—STK11—uterine cancer	9.2e-06	0.000317	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.2e-06	0.000317	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—STK11—uterine cancer	9.12e-06	0.000314	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP19A1—uterine cancer	9.12e-06	0.000314	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.96e-06	0.000309	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RRM2—uterine cancer	8.94e-06	0.000308	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—DCN—uterine cancer	8.68e-06	0.000299	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.56e-06	0.000295	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP11A1—uterine cancer	8.18e-06	0.000282	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.17e-06	0.000281	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—STK11—uterine cancer	7.8e-06	0.000269	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP19A1—uterine cancer	7.8e-06	0.000269	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKR1C3—uterine cancer	7.72e-06	0.000266	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—MTHFR—uterine cancer	7.52e-06	0.000259	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.32e-06	0.000252	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.98e-06	0.00024	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—MTHFR—uterine cancer	6.91e-06	0.000238	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PTEN—uterine cancer	6.86e-06	0.000236	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—MTHFR—uterine cancer	6.85e-06	0.000236	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.62e-06	0.000228	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—EP300—uterine cancer	6.54e-06	0.000225	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.04e-06	0.000208	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP19A1—uterine cancer	6.02e-06	0.000207	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—STK11—uterine cancer	6.02e-06	0.000207	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—MTHFR—uterine cancer	5.86e-06	0.000202	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PTEN—uterine cancer	5.53e-06	0.000191	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PTEN—uterine cancer	5.42e-06	0.000187	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—EP300—uterine cancer	5.28e-06	0.000182	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—EP300—uterine cancer	5.17e-06	0.000178	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.16e-06	0.000178	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—PIK3CA—uterine cancer	4.84e-06	0.000167	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—MTHFR—uterine cancer	4.52e-06	0.000156	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PTEN—uterine cancer	4.18e-06	0.000144	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—EP300—uterine cancer	3.99e-06	0.000137	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—AKT1—uterine cancer	3.95e-06	0.000136	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.9e-06	0.000135	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PTEN—uterine cancer	3.85e-06	0.000133	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—PIK3CA—uterine cancer	3.82e-06	0.000132	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PTEN—uterine cancer	3.81e-06	0.000131	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—EP300—uterine cancer	3.67e-06	0.000126	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—EP300—uterine cancer	3.64e-06	0.000125	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PTEN—uterine cancer	3.26e-06	0.000112	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—AKT1—uterine cancer	3.19e-06	0.00011	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—AKT1—uterine cancer	3.12e-06	0.000108	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—EP300—uterine cancer	3.11e-06	0.000107	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.95e-06	0.000102	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.71e-06	9.35e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—PIK3CA—uterine cancer	2.69e-06	9.27e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PTEN—uterine cancer	2.51e-06	8.66e-05	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—AKT1—uterine cancer	2.41e-06	8.3e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—EP300—uterine cancer	2.4e-06	8.26e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—PIK3CA—uterine cancer	2.3e-06	7.92e-05	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—AKT1—uterine cancer	2.22e-06	7.64e-05	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—AKT1—uterine cancer	2.2e-06	7.57e-05	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—AKT1—uterine cancer	1.88e-06	6.47e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.77e-06	6.11e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—AKT1—uterine cancer	1.45e-06	4.99e-05	CbGpPWpGaD
